326030 — SK Biopharmaceuticals Co Share News
0.000.00%
Last trade - 00:00- KR₩6tn
- KR₩6tn
- KR₩707bn
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract
Ir Meeting Scheduled For May 20-21, 2026
Brief: SK Biopharmaceuticals Co Q1 Preliminary Operating Profit 89.8 Billion Won Up 249.7% Y/Y
Brief: Sk Biopharmaceuticals Co Wins 843 Billion Won Contract
Shares of Asian drugmakers drop after Trump threatens tariffs (updated)
Shares of South Korea’s drugmakers drop after Trump unveils tariffs
Brief: Sk Biopharmaceuticals Q3 Operating Profit 19.3 Billion Won, Swings To Profit From Year Earlier
Brief: Sk Biopharmaceuticals Q2 Operating Profit 26 Billion Won, Swings To Profit From Year Earlier
Brief: Sk Biopharmaceuticals Wins 38.6 Billion Won Order
Brief: Sk Biopharmaceuticals Wins 49 Billion Won Order
Brief: Sk Biopharmaceuticals Q2 Operating Loss 19 Billion Won, Up 52.7% From Year Earlier
Brief: Sk Biopharmaceuticals Wins 37 Billion Won Order
Brief: Sk Biopharmaceuticals To Acquire Shares Worth 62 Billion Won In Proteovant Sciences Inc
Brief: Sk Biopharmaceuticals Wins 47 Billion Won Order
Brief: Sk Biopharmaceuticals Wins 14 Billion Won Order
Brief: Sk Biopharmaceuticals Co To Invest $20 Million In Lifesci Venture Partners Iii, Lp